In AD patients with moderate dementia, the increase of S100B levels is followed by a 10-fold increase in auto-antibodies: however, in AD patients with severe dementia the levels of auto-antibodies remain identical to controls (Gruden et al., 2007), indicating that there is no immune-protection against elevated S100B levels in AD patients with severe dementia. Here, S100B is linked to Alzheimer disease.